Whereas MARCH5 is neuroprotective under conditions of insufficient protein quality control as seen e.g. in Machado-Joseph disease [15], its expression has no beneficial effect under glaucoma-relevant stress conditions. This evidence concerns the gene MARCHF5 and Machado-Joseph disease.